Last update 01 Nov 2024
Xinjiang Xinziyuan Biopharmaceutical Co., Ltd
Last update 01 Nov 2024
Overview
Related
地屈孕酮片在中国健康女性受试者中进行的单中心、随机、开放、单次（空腹/餐后）口服给药、两制剂、两序列、四周期、完全重复交叉的人体生物等效性试验。
[Translation] This is a single-center, randomized, open-label, single (fasting/postprandial) oral bioequivalence study of dydrogesterone tablets conducted in healthy Chinese female subjects. The study involved two preparations, two sequences, four cycles, and a complete repeated crossover.
100 Clinical Results associated with Xinjiang Xinziyuan Biopharmaceutical Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Xinjiang Xinziyuan Biopharmaceutical Co., Ltd
Login to view more data
100 Translational Medicine associated with Xinjiang Xinziyuan Biopharmaceutical Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Nov 2024
No data posted
Login to keep update
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free